Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126582371 | 12658237 | 1 | I | 20160804 | 20160817 | 20160817 | EXP | IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-122001 | RANBAXY | DAS S, RAMASAMY A, DE S, MONDAL S. AN UNUSUAL CASE OF GLIPIZIDE-INDUCED PROXIMAL MYOPATHY. J PHARMACOL PHARMACOTHER. 2016;7(2):99-101 | 61.00 | YR | M | Y | 0.00000 | 20160817 | OT | IN | IN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126582371 | 12658237 | 1 | PS | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | UNK | Y | Y | 77820 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126582371 | 12658237 | 1 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126582371 | 12658237 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126582371 | 12658237 | Myopathy | Myopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |